UnitedHealth Group and Amedisys Inc. announced a new agreement on May 6, 2025, to sell certain home health and hospice locations to a third party. This divestiture is contingent on the successful closure of their proposed $3.3 billion merger.
This strategic move aims to address the antitrust concerns raised by the U.S. Department of Justice, which filed a lawsuit last year to block the acquisition. The sale of these assets is intended to alleviate fears of reduced competition in the home health services market.
The new deal demonstrates UnitedHealth's continued commitment to completing the Amedisys acquisition despite regulatory hurdles. It represents a proactive step to gain approval for a merger that would significantly expand its presence in home-based care.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.